William Ackman

10 results

Ryanair rose 4 per cent to close at €11.57 as analysts concluded it was better placed to weather a shake-out than its rivals.

An early recovery proved short-lived for European shares on Tuesday with no end in sight to the coronavirus outbreak, as a jump in infections across t(...)

Warren Buffett (85)  Charlie Munger (92) fielded five hours of questions on such matters as Coca-Cola’s sugary drinks, lower shipping volumes on the BNSF railroad, risks from derivatives, and who might succeed Buffett as chief executive.

Warren Buffett said on Saturday that Berkshire Hathaway Inc is poised to do well no matter who wins the White House in November, and the billionaire i(...)

 Valeant Pharmaceuticals International: firm’s  US shares rose about 8 per cent in premarket trading. Photograph: Christinne Muschi/Reuters

Valeant Pharmaceuticals International said its lenders had agreed to give it an extra month to file its annual report, providing further reassurance t(...)

The headquarters of Valeant Pharmaceuticals in Laval, Quebec. Photograph: Christinne Muschi/ Reuters

Embattled pharmaceutical company Valeant said its chief executive Michael Pearson will step down as it added Bill Ackman, one of its largest investors(...)

Topping the list is Kenneth Griffin, who started by trading convertible bonds out of his dormitory at Harvard. He took home $1.3 billion last year. (Photograph: Mario Anzuoni/Reuters)

For investors in hedge funds, like big pension funds, 2014 was not a lucrative year. But for those who managed the investors’ money, the pay was spect(...)

Some of the worst-performing funds in 2014 were ones managed by John Paulson, who rose to fame by making billions of dollars from a shrewd bet against the US housing market in the runup to the financial crisis.

If Steven A Cohen’s investment firm were operating as a hedge fund, it would have been one of the industry’s most profitable in 2014. Mr Cohen’s famil(...)

A doctor injects a patient with Allergan’s Botox. Photographer: Patrick T. Fallon/Bloomberg

Botox maker Allergan, which is fending off an acquisition by Valeant Pharmaceuticals, said today that it had been approached by another party regardi(...)

Botox producer Allergan  is resisting Valeant’s hostile offer. Photograph: Shannon Stapleton/Reuters

Valeant Pharmaceuticals said in a letter yesterday to Allergan’s board of directors that it was prepared to raise its offer to at least $200 per share(...)

Billionaire investor William Ackman. Photograph: Scott Eells/Bloomberg

A few months ago an innovative partnership between Valeant Pharmaceuticals and billionaire investor William Ackman to buy Botox maker Allergan look(...)

 William Ackman: founder and chief executive  of Pershing Square Capital Management LP.   Photograph: Scott Eells/Bloomberg

Hedge fund billionaire William Ackman has quit the board of troubled department store group JC Penney, ending three years of acrimony.The company anno(...)